常規時段
|
|
|
|
|
||||||||||||
|
|
|
|
|
|
|
|
價值評估 |
盈利(現時/預測)
-3.78/-0.63
|
企業價值
48.49M
|
資產負債 |
每股賬面淨值
1.80
|
現金流量 |
現金流量率
--
|
損益表 |
收益
500.00K
|
每股收益
3.77
|
同行比較
|
||||||||||||||||||||||||||||||||||||||||||||||||
|

同行比較之報價最少15分鐘延遲
業務概覽
|
|||
Exicure Inc is an early-stage biotechnology company focused on developing nucleic acid therapies targeting ribonucleic acid against validated targets. It operates in a single segment which is Biotechnology. |